Market Cap 102.29M
Revenue (ttm) 0.00
Net Income (ttm) -147.27M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 71,800
Avg Vol 253,836
Day's Range N/A - N/A
Shares Out 50.14M
Stochastic %K 24%
Beta 0.77
Analysts Hold
Price Target $1.92

Company Profile

HilleVax, Inc., a clinical-stage biopharmaceutical company, develops and commercializes vaccines in the United States. The company develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. It has a license agreement with Takeda Vaccines, Inc. to develop and commercialize HIL-214 pharmaceutical products. The company was formerly known as MokshaCo, Inc. and changed its name to HilleVax, Inc. in Febr...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 213 5054
Address:
321 Harrison Avenue, 5th Fl., Boston, United States
ZorTrades
ZorTrades Jul. 29 at 5:39 PM
🚨 Fresh 13G/13D Filings – Smart Money Moves: 📈 $CTNM – Contineum Therapeutics RA Capital: Top-tier biotech VC/hedge fund led by Peter Kolchinsky, focused on early-to-mid stage healthcare. 🧬 New 2.12M share stake (9.9% of float) — 100% new 📈 $HLVX – HilleVax EcoR1 Capital: Biotech specialist hedge fund run by Oleg Nodelman, known for early innovation bets. 💉 New 2.89M share stake (5.8% of float) — 100% new 📈 $ELBM – Electra Battery Materials Highbridge Capital: Multi-strategy hedge fund founded by Scott Kapnick (ex-Goldman), active in distressed and special sits. 🔋 New 3.59M share stake (9.9% of float) — 100% new All filed late July 2025.
1 · Reply
mikedumbledar
mikedumbledar Jul. 21 at 2:09 PM
$HLVX this is one of the major problems in the biotech industry. management in biotech sector is really poor and investors don’t trust them to follow their fiduciary responsibility $XBI
0 · Reply
Suh420
Suh420 Jul. 19 at 12:33 AM
$NWBO look at $HLVX breakout peeps. The setup is clean and we are pressing it soon!
1 · Reply
Suh420
Suh420 Jul. 19 at 12:31 AM
$GOVX is crap. Look at $HLVX chart and fundamentals. The breakout setup is 10x cleaner and waay better % gain potential. Plus no dilution risk or cash raise need
0 · Reply
Suh420
Suh420 Jul. 19 at 12:28 AM
$MEIP is $HLVX little brother. Big strategic alternative move coming here in this micro cap with over $150MILLION cash and a less than >10mil float. Massive Multi Month Breakout level
0 · Reply
warpdrive1
warpdrive1 Jun. 4 at 2:09 PM
$HLVX strategic alternatives incoming
0 · Reply
WAYWARD_SUN
WAYWARD_SUN May. 19 at 2:41 PM
0 · Reply
joe77w
joe77w May. 8 at 1:19 PM
$HLVX 10Q out 3 usd in net equity https://www.otcmarkets.com/filing/html?id=18445085&guid=eeV-kFzAdOPedth
0 · Reply
PenkeTrading
PenkeTrading May. 1 at 12:48 PM
I found you an Overbought RSI (Relative Strength Index) on the daily chart of Hillevax Inc. Is that bullish or bearish? $HLVX #Hillevax #RsiOverbought #NASDAQ
0 · Reply
JarvisFlow
JarvisFlow Mar. 31 at 11:00 AM
HC Wainwright & Co. has updated their rating for HilleVax ( $HLVX ) to Neutral with a price target of 2.
0 · Reply
Latest News on HLVX
Frazier Life Sciences Appoints Aditya Kohli to Partner

Apr 17, 2025, 8:00 AM EDT - 3 months ago

Frazier Life Sciences Appoints Aditya Kohli to Partner

PHAT


Gold Falls Over 1%; HilleVax Shares Plunge

Jul 8, 2024, 2:31 PM EDT - 1 year ago

Gold Falls Over 1%; HilleVax Shares Plunge


ZorTrades
ZorTrades Jul. 29 at 5:39 PM
🚨 Fresh 13G/13D Filings – Smart Money Moves: 📈 $CTNM – Contineum Therapeutics RA Capital: Top-tier biotech VC/hedge fund led by Peter Kolchinsky, focused on early-to-mid stage healthcare. 🧬 New 2.12M share stake (9.9% of float) — 100% new 📈 $HLVX – HilleVax EcoR1 Capital: Biotech specialist hedge fund run by Oleg Nodelman, known for early innovation bets. 💉 New 2.89M share stake (5.8% of float) — 100% new 📈 $ELBM – Electra Battery Materials Highbridge Capital: Multi-strategy hedge fund founded by Scott Kapnick (ex-Goldman), active in distressed and special sits. 🔋 New 3.59M share stake (9.9% of float) — 100% new All filed late July 2025.
1 · Reply
mikedumbledar
mikedumbledar Jul. 21 at 2:09 PM
$HLVX this is one of the major problems in the biotech industry. management in biotech sector is really poor and investors don’t trust them to follow their fiduciary responsibility $XBI
0 · Reply
Suh420
Suh420 Jul. 19 at 12:33 AM
$NWBO look at $HLVX breakout peeps. The setup is clean and we are pressing it soon!
1 · Reply
Suh420
Suh420 Jul. 19 at 12:31 AM
$GOVX is crap. Look at $HLVX chart and fundamentals. The breakout setup is 10x cleaner and waay better % gain potential. Plus no dilution risk or cash raise need
0 · Reply
Suh420
Suh420 Jul. 19 at 12:28 AM
$MEIP is $HLVX little brother. Big strategic alternative move coming here in this micro cap with over $150MILLION cash and a less than >10mil float. Massive Multi Month Breakout level
0 · Reply
warpdrive1
warpdrive1 Jun. 4 at 2:09 PM
$HLVX strategic alternatives incoming
0 · Reply
WAYWARD_SUN
WAYWARD_SUN May. 19 at 2:41 PM
0 · Reply
joe77w
joe77w May. 8 at 1:19 PM
$HLVX 10Q out 3 usd in net equity https://www.otcmarkets.com/filing/html?id=18445085&guid=eeV-kFzAdOPedth
0 · Reply
PenkeTrading
PenkeTrading May. 1 at 12:48 PM
I found you an Overbought RSI (Relative Strength Index) on the daily chart of Hillevax Inc. Is that bullish or bearish? $HLVX #Hillevax #RsiOverbought #NASDAQ
0 · Reply
JarvisFlow
JarvisFlow Mar. 31 at 11:00 AM
HC Wainwright & Co. has updated their rating for HilleVax ( $HLVX ) to Neutral with a price target of 2.
0 · Reply
d_risk
d_risk Mar. 30 at 5:22 PM
$HLVX - HilleVax Inc. Common Stock - 10K - Updated Risk Factors HLVX's 2025 10-K Risk Factors highlight a strategic pivot from HIL-214 to broader norovirus vaccine candidates, emphasizing regulatory, patent, and commercialization challenges, workforce reductions, and increased reliance on third-party collaborations. New risks include potential Nasdaq delisting and geopolitical impacts on trade. #Biotechnology #GeopoliticalFactors #MarketCompetition #RegulatoryRisks #VaccineDevelopment 🟢 Added 🟠 Removed https://d-risk.ai/HLVX/10-K/2025-03-28
0 · Reply
NVDAMillionaire
NVDAMillionaire Mar. 21 at 6:10 PM
$HLVX Tough break for HLVX. Norovirus vaccine miss is brutal. Might see some consolidation before potential pivot. Adult trial could be interesting play. Watching closely for strategic moves. solid article: https://beyondspx.com/article/hillevax-hlvx-navigating-the-challenges-of-norovirus-vaccine-development
0 · Reply
sivagnanam
sivagnanam Feb. 13 at 4:12 AM
0 · Reply
TrendSetter67
TrendSetter67 Jan. 4 at 9:55 PM
$VXRT After reading this publication on enterics, how can $MRNA believe they will perform well with their Norovirus vaccine? They are on the same failed track as $HLVX. You can't protect against an intestinal virus with a needle in the arm. Oral/pill directly into the gut is the WAY. 💊 https://pmc.ncbi.nlm.nih.gov/articles/PMC9257994/
0 · Reply
Suh420
Suh420 Jan. 3 at 1:46 AM
$HLVX at Massive Key Breakout Level right now! $NIRO $QNCCF
0 · Reply
TrendSetter67
TrendSetter67 Jan. 2 at 5:53 PM
$VXRT Lesson to be learned... Pill/GALT vs Jab/Intramuscular. You can't protect against a disease of the gut (Enteric) with a needle in the arm. Mucosal protection via intestinal Peyer's Patches vaccine uptake is the Way. $HLVX only achieved 5% field efficacy. Are the $MRNA fans listening? Do you know your IgA measurements? Only Vaxart have worked out the true Norovirus Correlates of Protection.
2 · Reply
Tumble51
Tumble51 Dec. 23 at 12:02 AM
$WHWK $HLVX $LOGC $QURE Anyone that sells QURE, is a smart investor, their ceo sucks.
0 · Reply
jackcoltrain
jackcoltrain Dec. 21 at 1:18 AM
$QURE nice 171% gain since I rotated some $LOGC to this stock. I'm planning to sell some QURE to buy $HLVX. Missed out on $WHWK unfortunately
0 · Reply
TI7812
TI7812 Dec. 21 at 12:54 AM
$HLVX what could happen 2025 from their 3Q24 cash $189.3M marketable securities $303M a) liquidation of the company and return money to shareholders. Execs then have no income and have to find a job - https://x.com/Lord_of_Biotech/status/1815710509586342315 b) they buy some private biotech or a public biotech and execs get back on the biotech shitco gravy train. Maybe Tang "sells" them something he owns fully or partially to get access to that $500 million sitting in banks and burn through that too long small spec amount bought today to see what happens in 2025. small enough that I'll just ignore it.
1 · Reply
NVDAMillionaire
NVDAMillionaire Dec. 11 at 2:28 PM
$HLVX HilleVax (HLVX): Navigating the Evolving Norovirus Vaccine Landscape https://beyondspx.com/article/hillevax-hlvx-navigating-the-evolving-norovirus-vaccine-landscape
0 · Reply
Kouradct
Kouradct Dec. 9 at 6:57 PM
0 · Reply
OpenOutcrier
OpenOutcrier Dec. 6 at 1:29 PM
$HLVX (+12.3% pre) HilleVax Shares Rise After Announcing Job Cuts, Executive Departures - MW https://ooc.bz/l/49951
0 · Reply